Journal of Cosmetics, Dermatological Sciences and Applications
Vol.5 No.2(2015), Paper ID 57124, 9
pages
DOI:10.4236/jcdsa.2015.52013
Treatment of Localized Vitiligo with 1% Pimecrolimus Cream versus 0.05% Clobetasol Propionate Cream—Single, Blinded, Comparative Therapeutic Trial
Khalifa E. Sharquie, Hayder R. Al-Hamamy, Adil A. Noaimi, Kholod A. Ali
Scientific Council of Dermatology and Venereologyl, Iraqi and Arab Board for Medical Specializations, Department of Dermatology, Collage of Medicine, University of Baghdad, Baghdad, Iraq
Scientific Council of Dermatology and Venereology, Iraqi Board for Medical specializations, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq
Scientific Council of Dermatology and Venereologyl, Iraqi and Arab Board for Medical Specializations, Department of Dermatology, Collage of Medicine, University of Baghdad, Baghdad, Iraq
Department of Dermatology & Venereology, Baghdad Teaching Hospital, Baghdad, Iraq
Copyright © 2015 Khalifa E. Sharquie, Hayder R. Al-Hamamy, Adil A. Noaimi, Kholod A. Ali et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Sharquie, K. , Al-Hamamy, H. , Noaimi, A. and Ali, K. (2015) Treatment of Localized Vitiligo with 1% Pimecrolimus Cream versus 0.05% Clobetasol Propionate Cream—Single, Blinded, Comparative Therapeutic Trial.
Journal of Cosmetics, Dermatological Sciences and Applications,
5, 107-115. doi:
10.4236/jcdsa.2015.52013.